226 related articles for article (PubMed ID: 21870996)
1. Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells.
Rodríguez JA; Luria-Pérez R; López-Valdés HE; Casero D; Daniels TR; Patel S; Avila D; Leuchter R; So S; Ortiz-Sánchez E; Bonavida B; Martínez-Maza O; Charles AC; Pellegrini M; Helguera G; Penichet ML
Leuk Lymphoma; 2011 Nov; 52(11):2169-78. PubMed ID: 21870996
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.
Daniels-Wells TR; Widney DP; Leoh LS; Martínez-Maza O; Penichet ML
J Immunother; 2015 Oct; 38(8):307-10. PubMed ID: 26325374
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma.
Leoh LS; Kim YK; Candelaria PV; Martínez-Maza O; Daniels-Wells TR; Penichet ML
J Immunol; 2018 May; 200(10):3485-3494. PubMed ID: 29654211
[TBL] [Abstract][Full Text] [Related]
4. An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies.
Daniels TR; Ortiz-Sánchez E; Luria-Pérez R; Quintero R; Helguera G; Bonavida B; Martínez-Maza O; Penichet ML
J Immunother; 2011; 34(6):500-8. PubMed ID: 21654517
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.
Leoh LS; Morizono K; Kershaw KM; Chen IS; Penichet ML; Daniels-Wells TR
J Gene Med; 2014; 16(1-2):11-27. PubMed ID: 24436117
[TBL] [Abstract][Full Text] [Related]
6. Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV
Martínez LE; Daniels-Wells TR; Guo Y; Magpantay LI; Candelaria PV; Penichet ML; Martínez-Maza O; Epeldegui M
Mol Cancer Ther; 2021 Sep; 20(9):1592-1602. PubMed ID: 34158342
[TBL] [Abstract][Full Text] [Related]
7. Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.
Candelaria PV; Leoh LS; Penichet ML; Daniels-Wells TR
Front Immunol; 2021; 12():607692. PubMed ID: 33815364
[TBL] [Abstract][Full Text] [Related]
8. Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.
Daniels-Wells TR; Helguera G; Rodríguez JA; Leoh LS; Erb MA; Diamante G; Casero D; Pellegrini M; Martínez-Maza O; Penichet ML
Toxicol In Vitro; 2013 Feb; 27(1):220-31. PubMed ID: 23085102
[TBL] [Abstract][Full Text] [Related]
9. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.
Herbison CE; Thorstensen K; Chua AC; Graham RM; Leedman P; Olynyk JK; Trinder D
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1567-75. PubMed ID: 19828835
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.
Suzuki E; Daniels TR; Helguera G; Penichet ML; Umezawa K; Bonavida B
Int J Oncol; 2010 May; 36(5):1299-307. PubMed ID: 20372806
[TBL] [Abstract][Full Text] [Related]
11. The hereditary hemochromatosis protein, HFE, lowers intracellular iron levels independently of transferrin receptor 1 in TRVb cells.
Carlson H; Zhang AS; Fleming WH; Enns CA
Blood; 2005 Mar; 105(6):2564-70. PubMed ID: 15528318
[TBL] [Abstract][Full Text] [Related]
12. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma.
Shimosaki S; Nakahata S; Ichikawa T; Kitanaka A; Kameda T; Hidaka T; Kubuki Y; Kurosawa G; Zhang L; Sudo Y; Shimoda K; Morishita K
Biochem Biophys Res Commun; 2017 Mar; 485(1):144-151. PubMed ID: 28189691
[TBL] [Abstract][Full Text] [Related]
13. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.
Neiveyans M; Melhem R; Arnoult C; Bourquard T; Jarlier M; Busson M; Laroche A; Cerutti M; Pugnière M; Ternant D; Gaborit N; Chardès T; Poupon A; Gouilleux-Gruart V; Pèlegrin A; Poul MA
MAbs; 2019 Apr; 11(3):593-605. PubMed ID: 30604643
[TBL] [Abstract][Full Text] [Related]
14. Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.
Leoh LS; Daniels-Wells TR; Martínez-Maza O; Penichet ML
Mol Immunol; 2015 Oct; 67(2 Pt B):407-15. PubMed ID: 26232328
[TBL] [Abstract][Full Text] [Related]
15. Development of a complete human anti-human transferrin receptor C antibody as a novel marker of oral dysplasia and oral cancer.
Nagai K; Nakahata S; Shimosaki S; Tamura T; Kondo Y; Baba T; Taki T; Taniwaki M; Kurosawa G; Sudo Y; Okada S; Sakoda S; Morishita K
Cancer Med; 2014 Aug; 3(4):1085-99. PubMed ID: 24890018
[TBL] [Abstract][Full Text] [Related]
16. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency.
Jabara HH; Boyden SE; Chou J; Ramesh N; Massaad MJ; Benson H; Bainter W; Fraulino D; Rahimov F; Sieff C; Liu ZJ; Alshemmari SH; Al-Ramadi BK; Al-Dhekri H; Arnaout R; Abu-Shukair M; Vatsayan A; Silver E; Ahuja S; Davies EG; Sola-Visner M; Ohsumi TK; Andrews NC; Notarangelo LD; Fleming MD; Al-Herz W; Kunkel LM; Geha RS
Nat Genet; 2016 Jan; 48(1):74-8. PubMed ID: 26642240
[TBL] [Abstract][Full Text] [Related]
17. EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1.
Wang B; Zhang J; Song F; Tian M; Shi B; Jiang H; Xu W; Wang H; Zhou M; Pan X; Gu J; Yang S; Jiang L; Li Z
Cancer Lett; 2016 Oct; 381(2):331-40. PubMed ID: 27523281
[TBL] [Abstract][Full Text] [Related]
18. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.
Li L; Fang CJ; Ryan JC; Niemi EC; Lebrón JA; Björkman PJ; Arase H; Torti FM; Torti SV; Nakamura MC; Seaman WE
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3505-10. PubMed ID: 20133674
[TBL] [Abstract][Full Text] [Related]
19. Transferrin and transferrin receptors update.
Kawabata H
Free Radic Biol Med; 2019 Mar; 133():46-54. PubMed ID: 29969719
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy.
Ikuta K; Yersin A; Ikai A; Aisen P; Kohgo Y
J Mol Biol; 2010 Mar; 397(2):375-84. PubMed ID: 20096706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
